The opportunistic pathogen Pseudomonas aeruginosa is often involved in airway infections of cystic fibrosis (CF) patients. It persists in the hostile CF lung environment, inducing chronic infections due to the production of several virulence factors. In this regard, the ability to form a biofilm plays a pivotal role in CF airway colonization by P. aeruginosa. Bacterial virulence mitigation and bacterial cell adhesion hampering and/or biofilm reduced formation could represent a major target for the development of new therapeutic treatments for infection control. Essential oils (EOs) are being considered as a potential alternative in clinical settings for the prevention, treatment, and control of infections sustained by microbial biofilms. EOs are complex mixtures of different classes of organic compounds, usually used for the treatment of upper respiratory tract infections in traditional medicine. Recently, a wide series of EOs were investigated for their ability to modulate biofilm production by different pathogens comprising S. aureus, S. epidermidis, and P. aeruginosa strains. Machine learning (ML) algorithms were applied to develop classification models in order to suggest a possible antibiofilm action for each chemical component of the studied EOs. In the present study, we assessed the biofilm growth modulation exerted by 61 commercial EOs on a selected number of P. aeruginosa strains isolated from CF patients. Furthermore, ML has been used to shed light on the EO chemical components likely responsible for the positive or negative modulation of bacterial biofilm formation.

Essential oils biofilm modulation activity and machine learning analysis on Pseudomonas aeruginosa isolates from cystic fibrosis patients / Artini, M.; Papa, R.; Sapienza, F.; Božovic ́, M.; Vrenna, G.; Tuccio Guarna Assanti, V.; Sabatino, M.; Garzoli, S.; Fiscarelli, E. V.; Ragno, R.; Selan, L.. - In: MICROORGANISMS. - ISSN 2076-2607. - 10:5(2022), pp. 1-14. [10.3390/microorganisms10050887]

Essential oils biofilm modulation activity and machine learning analysis on Pseudomonas aeruginosa isolates from cystic fibrosis patients

Artini, M.;Papa, R.;Sapienza, F.;Vrenna, G.;Sabatino, M.;Garzoli, S.;Ragno, R.
;
Selan, L.
2022

Abstract

The opportunistic pathogen Pseudomonas aeruginosa is often involved in airway infections of cystic fibrosis (CF) patients. It persists in the hostile CF lung environment, inducing chronic infections due to the production of several virulence factors. In this regard, the ability to form a biofilm plays a pivotal role in CF airway colonization by P. aeruginosa. Bacterial virulence mitigation and bacterial cell adhesion hampering and/or biofilm reduced formation could represent a major target for the development of new therapeutic treatments for infection control. Essential oils (EOs) are being considered as a potential alternative in clinical settings for the prevention, treatment, and control of infections sustained by microbial biofilms. EOs are complex mixtures of different classes of organic compounds, usually used for the treatment of upper respiratory tract infections in traditional medicine. Recently, a wide series of EOs were investigated for their ability to modulate biofilm production by different pathogens comprising S. aureus, S. epidermidis, and P. aeruginosa strains. Machine learning (ML) algorithms were applied to develop classification models in order to suggest a possible antibiofilm action for each chemical component of the studied EOs. In the present study, we assessed the biofilm growth modulation exerted by 61 commercial EOs on a selected number of P. aeruginosa strains isolated from CF patients. Furthermore, ML has been used to shed light on the EO chemical components likely responsible for the positive or negative modulation of bacterial biofilm formation.
2022
biofilm modulation; pseudomonas aeruginosa; cystic fibrosis; machine learning; essential oil
01 Pubblicazione su rivista::01a Articolo in rivista
Essential oils biofilm modulation activity and machine learning analysis on Pseudomonas aeruginosa isolates from cystic fibrosis patients / Artini, M.; Papa, R.; Sapienza, F.; Božovic ́, M.; Vrenna, G.; Tuccio Guarna Assanti, V.; Sabatino, M.; Garzoli, S.; Fiscarelli, E. V.; Ragno, R.; Selan, L.. - In: MICROORGANISMS. - ISSN 2076-2607. - 10:5(2022), pp. 1-14. [10.3390/microorganisms10050887]
File allegati a questo prodotto
File Dimensione Formato  
Artini_Essential_oils_2022.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 1.42 MB
Formato Adobe PDF
1.42 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1635652
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 11
social impact